Regulation of Xist RNA processing in embryonic stem cells

胚胎干细胞中 Xist RNA 加工的调控

基本信息

项目摘要

DESCRIPTION (provided by applicant): ABSTRACT Non-coding RNAs with gene regulatory functions are starting to be seen as a common feature of mammalian gene regulation with the discovery that most of the transcriptome is non-coding RNA. Given that a significant proportion of the genome encodes non-coding RNAs, relatively little is known about the regulatory mechanisms and functions of these RNAs. Thus, new insights into how non-coding RNAs are regulated and how they regulate gene expression are essential for a complete understanding of mammalian gene expression. We employ X chromosome inactivation as a model system to study the regulation and function of non-coding RNAs. X-inactivation is the developmentally regulated transcriptional silencing of one X chromosome in female cells, used to equalize X-linked gene dosage with male cells. An antisense pair of non-coding RNAs, Xist and Tsix RNA, are central in the regulation of X-inactivation. X-inactivation is random - the X chromosome from each parent is silenced with equal frequency. Xist and Tsix RNA are expressed before the onset of X chromosome silencing and are necessary for X-inactivation to occur randomly. In Xist or Tsix mutant cells, X-inactivation is non-random and the fates of the mutant and the wild-type X chromosomes are fixed. Xist and Tsix mutations have opposite effects on X chromosome fate: an Xist mutant chromosome is always chosen as the active X and a Tsix mutant X chromosome is always chosen as the inactive X. Xist and Tsix also negatively regulate each other's expression, forming a feedback loop. In this proposal we dissect the Xist/Tsix feedback loop and explore how it is used to ensure that each X chromosome has an equal frequency of being silenced. PUBLIC HEALTH RELEVANCE: Project Narrative (Public Health Relevance) Non-coding RNAs play critical roles in regulating DNA structure, RNA expression, and translation, and thus affect normal development. While non-coding RNAs are already being identified as markers for cancer and associated with other complex diseases such as coronary disease and diabetes, little is understood about their regulation and function. A better understanding of non-coding RNAs will undoubtedly be important in the diagnosis and treatment of these conditions. We use X-inactivation as a model system to study the regulation and function of non-coding RNAs. In mammalian female cells, one X chromosome is silenced. This silencing ensures that X-linked gene dosage in XX female cells is equivalent to that in XY male cells. This process is essential for the survival of females. A pair of non- coding RNAs, Xist and Tsix RNA, is central in the regulation of X-inactivation. In this submission, we propose to study the regulation and function of Xist and Tsix RNA. What we learn will undoubtedly contribute to our understanding of X-inactivation, and more generally to the function of non-coding RNAs.
描述(由申请人提供):摘要随着大部分转录组是非编码RNA的发现,具有基因调控功能的非编码RNA开始被视为哺乳动物基因调控的共同特征。鉴于基因组中有很大一部分编码非编码RNA,对这些RNA的调控机制和功能知之甚少。因此,对非编码RNA如何调节以及它们如何调节基因表达的新见解对于完整理解哺乳动物基因表达至关重要。我们采用X染色体失活作为模型系统来研究非编码RNA的调控和功能。X-失活是发育调节的转录沉默的一个X染色体在女性细胞中,用于平衡X连锁基因剂量与男性细胞。一对反义非编码RNA,Xist和Tsix RNA,在X失活的调节中是中心的。X染色体失活是随机的--每个亲本的X染色体以相同的频率沉默。Xist和Tsix RNA在X染色体沉默开始之前表达,并且是X失活随机发生所必需的。在Xist或Tsix突变体细胞中,X失活是非随机的,并且突变体和野生型X染色体的命运是固定的。Xist和Tsix突变对X染色体的命运有相反的影响:Xist突变染色体总是被选为活性X,Tsix突变X染色体总是被选为非活性X。Xist和Tsix也负调节彼此的表达,形成反馈回路。在这个提议中,我们剖析了Xist/Tsix反馈回路,并探索如何使用它来确保每个X染色体具有相同的沉默频率。 公共卫生相关性:非编码RNA在调节DNA结构、RNA表达和翻译中起着关键作用,从而影响正常发育。虽然非编码RNA已经被确定为癌症的标志物,并与其他复杂疾病如冠心病和糖尿病相关,但对它们的调节和功能知之甚少。更好地了解非编码RNA无疑对这些疾病的诊断和治疗非常重要。我们使用X-失活作为模型系统来研究非编码RNA的调控和功能。在哺乳动物雌性细胞中,一条X染色体被沉默。这种沉默确保XX雌性细胞中的X连锁基因剂量与XY雄性细胞中的剂量相等。这个过程对女性的生存至关重要。一对非编码RNA,Xist和Tsix RNA,在X-失活的调节中是中心的。在这篇论文中,我们打算研究Xist和Tsix RNA的调控和功能。我们所了解的无疑将有助于我们理解X-失活,更普遍的是非编码RNA的功能。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BARBARA PANNING其他文献

BARBARA PANNING的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BARBARA PANNING', 18)}}的其他基金

Control of bacterial infections by a horizontally acquired host peptidoglycan amidase
通过水平获得的宿主肽聚糖酰胺酶控制细菌感染
  • 批准号:
    10306384
  • 财政年份:
    2019
  • 资助金额:
    $ 28.11万
  • 项目类别:
Role of SOX2 O-GIcNAcylation in pluripotency
SOX2 O-GlcNAcNA 酰化在多能性中的作用
  • 批准号:
    9060597
  • 财政年份:
    2016
  • 资助金额:
    $ 28.11万
  • 项目类别:
Role of SOX2 O-GIcNAcylation in pluripotency
SOX2 O-GlcNAcNA 酰化在多能性中的作用
  • 批准号:
    9288190
  • 财政年份:
    2016
  • 资助金额:
    $ 28.11万
  • 项目类别:
Investigation of X chromosome organization before the onset of X-inactivation
X 失活发生前 X 染色体组织的研究
  • 批准号:
    8650906
  • 财政年份:
    2012
  • 资助金额:
    $ 28.11万
  • 项目类别:
Investigation of X chromosome organization before the onset of X-inactivation
X 失活发生前 X 染色体组织的研究
  • 批准号:
    8387975
  • 财政年份:
    2012
  • 资助金额:
    $ 28.11万
  • 项目类别:
REGULATION OF 3-D CHROMATIN ARCHITECTURE OF EMBRYONIC STEM CELLS
胚胎干细胞 3-D 染色质结构的调控
  • 批准号:
    8362740
  • 财政年份:
    2011
  • 资助金额:
    $ 28.11万
  • 项目类别:
POSTTRANSLATIONAL MODIFICATIONS ON HISTONES AND HISTONE VARIANTS
组蛋白和组蛋白变异体的翻译后修饰
  • 批准号:
    8363763
  • 财政年份:
    2011
  • 资助金额:
    $ 28.11万
  • 项目类别:
Regulation of Xist RNA processing in embryonic stem cells
胚胎干细胞中 Xist RNA 加工的调控
  • 批准号:
    8113864
  • 财政年份:
    2010
  • 资助金额:
    $ 28.11万
  • 项目类别:
POSTTRANSLATIONAL MODIFICATIONS ON HISTONES AND HISTONE VARIANTS
组蛋白和组蛋白变异体的翻译后修饰
  • 批准号:
    8169757
  • 财政年份:
    2010
  • 资助金额:
    $ 28.11万
  • 项目类别:
Regulation of Xist RNA processing in embryonic stem cells
胚胎干细胞中 Xist RNA 加工的调控
  • 批准号:
    8508949
  • 财政年份:
    2010
  • 资助金额:
    $ 28.11万
  • 项目类别:

相似国自然基金

基于小鼠多组织和细胞链特异性RNA-seq数据的Antisense RNA分析及数据库构建
  • 批准号:
    31271385
  • 批准年份:
    2012
  • 资助金额:
    95.0 万元
  • 项目类别:
    面上项目

相似海外基金

Investigating the Role of Antisense RNA in the CCL3/CCR5/RALY Pathway
研究反义 RNA 在 CCL3/CCR5/RALY 通路中的作用
  • 批准号:
    2611968
  • 财政年份:
    2021
  • 资助金额:
    $ 28.11万
  • 项目类别:
    Studentship
THE HUMAN BRAINOME III: EQTL REGULATION BY NATURAL ANTISENSE RNA IN ALZHEIMER S DISEASE
人类大脑 III:天然反义 RNA 对阿尔茨海默病的 EQTL 调节
  • 批准号:
    10651684
  • 财政年份:
    2020
  • 资助金额:
    $ 28.11万
  • 项目类别:
THE HUMAN BRAINOME III: EQTL REGULATION BY NATURAL ANTISENSE RNA IN ALZHEIMER S DISEASE
人类大脑 III:天然反义 RNA 对阿尔茨海默病的 EQTL 调节
  • 批准号:
    10450115
  • 财政年份:
    2020
  • 资助金额:
    $ 28.11万
  • 项目类别:
THE HUMAN BRAINOME III: EQTL REGULATION BY NATURAL ANTISENSE RNA IN ALZHEIMER S DISEASE
人类大脑 III:天然反义 RNA 对阿尔茨海默病的 EQTL 调节
  • 批准号:
    10033207
  • 财政年份:
    2020
  • 资助金额:
    $ 28.11万
  • 项目类别:
THE HUMAN BRAINOME III: EQTL REGULATION BY NATURAL ANTISENSE RNA IN ALZHEIMER S DISEASE
人类大脑 III:天然反义 RNA 对阿尔茨海默病的 EQTL 调节
  • 批准号:
    10256018
  • 财政年份:
    2020
  • 资助金额:
    $ 28.11万
  • 项目类别:
An antisense RNA-mediated regulatory program that drives cancer metastasis
反义RNA介导的驱动癌症转移的调控程序
  • 批准号:
    10435493
  • 财政年份:
    2019
  • 资助金额:
    $ 28.11万
  • 项目类别:
An antisense RNA-mediated regulatory program that drives cancer metastasis
反义RNA介导的驱动癌症转移的调控程序
  • 批准号:
    10652579
  • 财政年份:
    2019
  • 资助金额:
    $ 28.11万
  • 项目类别:
Alzheimer's Administrative Supplement - An antisense RNA-mediated regulatory program that drives cancer metastasis
阿尔茨海默氏症行政补充——一种驱动癌症转移的反义 RNA 介导的调控程序
  • 批准号:
    10117474
  • 财政年份:
    2019
  • 资助金额:
    $ 28.11万
  • 项目类别:
An antisense RNA-mediated regulatory program that drives cancer metastasis
反义RNA介导的驱动癌症转移的调控程序
  • 批准号:
    10177973
  • 财政年份:
    2019
  • 资助金额:
    $ 28.11万
  • 项目类别:
Isolation and characterization of novel peptides derived from antisense RNA
反义 RNA 衍生的新型肽的分离和表征
  • 批准号:
    19K06776
  • 财政年份:
    2019
  • 资助金额:
    $ 28.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了